Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.

Article  PubMed  Google Scholar 

Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47-64.

Article  PubMed  Google Scholar 

Mahmoudi A, Butler EA, De Vincentis A, Jamialahmadi T, Sahebkar A. Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis. Curr Med Chem. 2024;31(23):3631–52.

Article  CAS  Google Scholar 

Fernando DH, Forbes JM, Angus PW, Herath CB. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. Int J Mol Sci. 2019;20(20):5037.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kleiner DE, Makhlouf HR. Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children. Clin Liver Dis. 2016;20(2):293–312.

Article  PubMed  Google Scholar 

Mahmoudi A, Butler AE, Jamialahmadi T, Sahebkar A. The role of exosomal miRNA in nonalcoholic fatty liver disease. J Cell Physiol. 2022;237(4):2078–94.

Article  CAS  PubMed  Google Scholar 

Mantovani A, Dalbeni A. Treatments for NAFLD: state of art. Int J Mol Sci. 2021;22(5):2350.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahmoudi A, Butler AE, Jamialahmadi T, Sahebkar A. Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis. Biomed Res Int. 2021;2021:3654660.

Article  PubMed  PubMed Central  Google Scholar 

Mahmoudi A, Moallem SA, Johnston TP, Sahebkar A. Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models. PPAR Res. 2022;2022:5805398.

Article  PubMed  PubMed Central  Google Scholar 

Mahmoudi A, Jamialahmadi T, Johnston TP, Sahebkar A. Impact of fenofibrate on NAFLD/NASH: A genetic perspective. Drug Discovery Today. 2022;27(8):2363–72.

Article  CAS  PubMed  Google Scholar 

Mahmoudi A, Butler EA, Orekhov NA, Jamialahmadi T, Sahebkar A. Statins as a Potential Treatment for Non-alcoholic Fatty Liver Disease: Target Deconvolution using Protein-protein Interaction Network Analysis. Curr Med Chem. 2024;31:1–23.

Article  Google Scholar 

Mahmoudi A, Hajihasani MM, Majeed M, Jamialahmadi T, Sahebkar A. Effect of Calebin-A on Critical Genes Related to NAFLD: A Protein-Protein Interaction Network and Molecular Docking Study. Curr Genomics. 2024;25(2):120–39.

Article  CAS  PubMed  Google Scholar 

Mahmoudi A, Butler AE, Majeed M, Banach M, Sahebkar A. Investigation of the Effect of Curcumin on Protein Targets in NAFLD Using Bioinformatic Analysis. Nutrients. 2022;14(7):1331.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahmoudi A, Jalili A, Butler AE, Aghaee-Bakhtiari SH, Jamialahmadi T, Sahebkar A. Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets. J Clin Exp Hepatol. 2024;14(4): 101365.

Article  CAS  PubMed  Google Scholar 

Mahmoudi A, Rostami M, Mahdi Hajihasani M, Sukhorukov VN, Kesharwani P, Sahebkar A. siRNA-mediated gene silencing for non-alcoholic fatty liver disease: A comprehensive review of molecular targets. Eur Polymer J. 2024;208: 112866.

Article  CAS  Google Scholar 

Mahmoudi A, Jalili A, Aghaee-Bakhtiari SH, Oskuee RK, Butler AE, Rizzo M, Sahebkar A. Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease. J Diabetes Complications. 2024;38(4): 108722.

Article  CAS  PubMed  Google Scholar 

Jalili R, Somi MH, Hosseinifard H, Salehnia F, Ghojazadeh M, Makhdami N, Shirmohammadi M. The Evaluation of Effective Drugs for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. Advanced pharmaceutical bulletin. 2020;10(4):542.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miki T. Clinical hepatocyte transplantation. Gastroenterol Hepatol. 2019;42(3):202–8.

Article  PubMed  Google Scholar 

Shiota G, Itaba N. Progress in stem cell-based therapy for liver disease. Hepatology research : the official journal of the Japan Society of Hepatology. 2017;47(2):127–41.

Article  PubMed  Google Scholar 

Chrienova Z, Nepovimova E, Kuca K. The role of mTOR in age-related diseases. J Enzyme Inhib Med Chem. 2021;36(1):1679–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Selvarani R, Mohammed S, Richardson A. Effect of rapamycin on aging and age-related diseases-past and future. Geroscience. 2021;43(3):1135–58.

Article  CAS  PubMed  Google Scholar 

Ou YQ, Liu HY, Lu W, Wen MJ, Liu H. The mechanism of bone marrow-derived mesenchymal stem cells excessive senescence in severe aplastic anemia mouse model. Zhonghua Xue Ye Xue Za Zhi. 2017;38(4):325–9.

CAS  PubMed  Google Scholar 

Yun SP, Han Y-S, Lee JH, Kim SM, Lee SH. Melatonin rescues mesenchymal stem cells from senescence induced by the uremic toxin p-cresol via inhibiting mTOR-dependent autophagy. Biomolecules & therapeutics. 2018;26(4):389.

Article  CAS  Google Scholar 

Zhang D, Lu H, Chen Z, Wang Y, Lin J, Xu S, et al. High glucose induces the aging of mesenchymal stem cells via Akt/mTOR signaling. Mol Med Rep. 2017;16(2):1685–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ewald CY, Landis JN, Porter Abate J, Murphy CT, Blackwell TK. Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevity. Nature. 2015;519(7541):97–101.

Article  CAS  PubMed  Google Scholar 

Li H, Yu S, Hao F, Sun X, Zhao J, Xu Q, Duan D. Insulin-like growth factor binding protein 4 inhibits proliferation of bone marrow mesenchymal stem cells and enhances growth of neurospheres derived from the stem cells. Cell Biochem Funct. 2018;36(6):331–41.

Article  PubMed  Google Scholar 

Mano SS, Uto K, Ebara M. Material-induced Senescence (MIS): Fluidity Induces Senescent Type Cell Death of Lung Cancer Cells via Insulin-Like Growth Factor Binding Protein 5. Theranostics. 2017;7(19):4658–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kong CM, Subramanian A, Biswas A, Stunkel W, Chong YS, Bongso A, Fong CY. Changes in Stemness Properties, Differentiation Potential, Oxidative Stress, Senescence and Mitochondrial Function in Wharton’s Jelly Stem Cells of Umbilical Cords of Mothers with Gestational Diabetes Mellitus. Stem Cell Rev Rep. 2019;15(3):415–26.

Article  CAS  PubMed  Google Scholar 

Lu G, Wu Z, Shang J, Xie Z, Chen C, Zhang C. The effects of metformin on autophagy. Biomed Pharmacother. 2021;137: 111286.

Article  CAS  PubMed  Google Scholar 

Yun YC, Jeong SG, Kim SH, Cho GW. Reduced sirtuin 1/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol. J Tissue Eng Regen Med. 2019;13(1):110–5.

CAS  PubMed  Google Scholar 

Lee S, Le NH, Kang D. Melatonin alleviates oxidative stress-inhibited osteogenesis of human bone marrow-derived mesenchymal stem cells through AMPK activation. Int J Med Sci. 2018;15(10):1083–91.

Article  PubMed  PubMed Central